Аннотация
Представлен текст утвержденных в 2024 г. клинических рекомендаций Министерства здравоохранения Российской Федерации по лечению аномалии Эбштейна. Подробно приведены принципы, алгоритмы и шкалы оценки этиологии и патогенеза, эпидемиологии аномалии Эбштейна, классификация заболевания. Также освещены клиническая картина, диагностика и методы консервативного и хирургического лечения, реабилитации, диспансерного наблюдения. Представлены критерии оценки качества медицинской помощи.
Литература
-
Brown M.L., Dearani J.A., Danielson G.K., Cetta F., Connolly H.M., Warnes C.A. et al. Mayo Clinic Congenital Heart Center. The outcomes of operations for 539 patients with Ebstein anomaly. J. Thorac. Cardiovasc. Surg. 2008; 135 (5): 1120–1136, 1136.e1–7. DOI: 10.1016/j.jtcvs.2008.02.034
-
Бокерия Л.А., Шаталов К.В. Детская кардиохирургия. М.; 2016: 294–312.
-
Giamberti A., Chessa M. The tricuspid valve in congenital heart disease. Springer-Verlag Italia; 2014.
-
Бокерия Л.А., Подзолков В.П., Сабиров Б.Н. Аномалия Эбштейна. М.; 2005: 151–206.
-
Walsh E.P. Ebstein’s anomaly of the tricuspid valve: a Natural Laboratory for Re-Entrant Tachycardias. JACC Clin. Electrophysiol. 2018; 4 (10): 1271–1288. DOI: 10.1016/j.jacep.2018.05.024
-
Janson C.M., Shah M.J. Supraventricular tachycardia in adult congenital heart disease: mechanisms, diagnosis, and clinical aspects. Card. Electrophysiol Clin. 2017; 9 (2): 189–211. DOI: 10.1016/j.ccep.2017.02.005
-
Khairy P. Arrhythmias in adults with congenital heart disease: what the practicing cardiologist needs to know. Can. J. Cardiol. 2019; 35 (12): 1698–1707. DOI: 10.1016/j.cjca.2019.07.009
-
Mavroudis C., Dearani J.A. Atlas of adult congenital heart surgery. Springer Nature Switzerland AG; 2020.
-
Roten L., Lukac P., De Groot N., Nielsen J.C., Szili-Torok T., Jensen H.K. et al. Catheter ablation of arrhythmias in Ebstein’s anomaly: a multicenter study. J. Cardiovasc. Electrophysiol. 2011; 22 (12): 1391–1396. DOI: 10.1111/ j.1540-8167.2011.02161.x
-
Wackel P., Cannon B., Dearani J., Sessions K., Holst K., Johnson J., Cetta F. Arrhythmia after cone repair for Ebstein anomaly: the Mayo Clinic experience in 143 young patients. Congenit. Heart Dis. 2018; 13 (1): 26–30. DOI: 10.1111/chd.12566
-
Delhaas T., Sarvaas G.J., Rijlaarsdam M.E., Strengers J.L., Eveleigh R.M., Poulino S.E. et al. A multicenter, long-term study on arrhythmias in children with Ebstein anomaly. Pediatr. Cardiol. 2010; 31 (2): 229–233. DOI: 10.1007/s00246-009-9590-3
-
Raju V., Dearani J.A., Burkhart H.M., Grogan M., Phillips S.D., Ammash N. et al. Right ventricular unloading for heart failure related to Ebstein malformation. Ann. Thorac. Surg. 2014; 98 (1): 167–173; discussion 173–174. DOI: 10.1016/j.athoracsur.2014.03.009
-
Obioha-Ngwu O., Milliez P., Richardson A., Pittaro M., Josephson M.E. Ventricular tachycardia in Ebstein's Anomaly. Circulation. 2001; 104(18): E92–94. DOI: 10.1161/hc4301.098011
-
Shivapour J.K., Sherwin E.D., Alexander M.E., Cecchin F., Mah D.Y., Triedman J.K. et al. Tility of preoperative electrophysiologic studies in patients with Ebstein’s anomaly undergoing the Cone procedure. Heart Rhythm. 2014; 11 (2): 182–186. DOI: 10.1016/j.hrthm.2013. 10.045
-
Kubuš P., Vít P., Gebauer R.A., Materna O., Janoušek J. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circ. Arrhythm. Electrophysiol. 2014; 7 (2): 218–223. DOI: 10.1161/CIRCEP.113.000930
-
McIntosh N., Chitayat D., Bardanis M., Fouron J.C. Ebstein anomaly: report of a familial occurrence and prenatal diagnosis. Am. J. Med. Genet. 1992; 42 (3): 307–309. DOI: 10.1002/ajmg.1320420309
-
De Lonlay-Debeney P., de Blois M.C., Bonnet D., Amiel J., Abadie V., Picq M. et al. Ebstein anomaly associated with rearrangements of chromosomal region 11q. Am. J. Med. Genet. 1998; 80 (2): 157–159. DOI: 10.1002/(sici)1096-8628(19981102)80:2<157::aid- ajmg12>3.0.co;2-u
- Digilio M.C., Bernardini L., Lepri F., Giuffrida M.G., Guida V., Baban A. et al. Ebstein anomaly: genetic heterogeneity and association with microdeletions 1p36 and 8p23.1. Am. J. Med. Genet. A. 2011; 155A (9): 2196–2202. DOI: 10.1002/ajmg.a.34131
-
Harvey R.P. NK-2 homeobox genes and heart development. Develop. Biol. 1996; 178 (2): 203–216. DOI: 10.1006/dbio.1996.0212
-
Postma A.V., van Engelen K., van de Meerakker J. et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ. Cardiovasc. Genet. 2011; 4 (1): 43–50. DOI: 10.1161/CIRCGENETICS.110.957985
-
Пеняева Е.В. Генетические аспекты аномалии Эбштейна и связанных с ней заболеваний сердца. Вестник РАМН. 2021; 76 (1): 67–74.
-
Celermajer D.S., Cullen S., Sullivan I.D., Spiegelhalter D.J., Wyse R.K., Deanfield J.E. Outcome in neonates with Ebstein’s anomaly. J. Am. Coll. Cardiol. 1992; 19 (5): 1041–1046. DOI: 10.1016/0735-1097(92)90291-t
-
Бураковский В.И., Бокерия Л.А. (ред.) Сердечно-сосудистая хирургия: Руководство. М.; 1989: 471–512.
-
Lang D., Oberhoffer R., Cook A., Sharland G., Allan L., Fagg N., Anderson R.H. Pathologic spectrum of malformations of the tricuspid valve in prenatal and neonatal life. J. Am. Coll. Cardiol. 1991; 17 (5): 1161–1167. DOI: 10.1016/0735-1097(91)90848-4
-
Sharland G.K., Chita S.K., Allan L.D. Tricuspid valve dysplasia or displacement in intrauterine life. J. Am. Coll. Cardiol. 1991; 17 (4): 944–949. DOI: 10.1016/0735-1097(91)90877-c
-
Castaneda A.R., Jonas R.A., Mayer J.E., Hanley F.L. Ebstein’s anomaly. In: Cardiac surgery of the neonate and infant. 1994: 273–280.
-
Carpentier A., Chauvaud S., Macé L., Relland J., Mihaileanu S., Marino J.P. et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J. Thorac. Cardiovasc. Surg. 1988; 96 (1): 92–101.
-
Sano S., Fujii Y., Kasahara S., Kuroko Y., Tateishi A., Yoshizumi K., Arai S. Repair of Ebstein’s anomaly in neonates and small infants: impact of right ventricular exclusion and its indications. Eur. J. Cardiothorac. Surg. 2014; 45 (3): 549–555; discussion 555. DOI: 10.1093/ ejcts/ezt465
-
Mizuno M., Hoashi T., Sakaguchi H., Kagisaki K., Kitano M., Kurosaki K. et al. Application of cone reconstruction for neonatal Ebstein anomaly or tricuspid valve dysplasia. Ann. Thorac. Surg. 2016; 101 (5): 1811–1817. DOI: 10.1016/j.athoracsur.2015.11.029
- Stout K.K., Daniels C.J., Aboulhosn J.A., Bozkurt B., Broberg C.S., Colman J.M. et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: a Report of the American College of Cardiology / American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019; 73 (12): e81–e192. DOI: 10.1016/j.jacc.2018.08.1029
Erratum in: J. Am. Coll. Cardiol. 2019; 73 (18): 2361–2362. DOI: 10.1016/j.jacc.2019.03.018
-
Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P. et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur. Heart J. 2021; 42 (6): 563–645. DOI: 10.1093/eurheartj/ehaa554
-
Бокерия Л.А., Бокерия О.Л., Сабиров Б.Н., Тетвадзе И.В., Александрова М.Л., Черногривов И.Е., Мурзагалиев М.У. Современный подход и результаты одномоментной коррекции аномалии Эбштейна и синдрома Вольфа–Паркинсона–Уайта. Грудная и сердечно- сосудистая хирургия. 2012; 54 (1): 4–11.
- Caldeira D., David C., Costa J., Ferreira J.J., Pinto F.J. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis. Eur. Heart J. Cardiovasc. Pharmacother. 2018; 4 (2): 111–118. DOI: 10.1093/ehjcvp/pvx028
- Бокерия Л.А., Голухова Е.З., Ревишвили А.Ш., Левант А.Д., Дадашева М.А., Джитава Т.Г. и др. Дифференцированный подход к хирургическому лечению аномалии Эбштейна, сочетающейся с синдромом Вольфа–Паркинсона–Уайта. Грудная и сердечно- сосудистая хирургия. 2003; 2: 12–17.
- Долгов В.В. (ред.) Клиническая лабораторная диагностика: Учебник. М.: ФГБОУ ДПО «РМАНПО»; 2016.
- Brugada J., Katritsis D.G., Arbelo E., Arribas F., Bax J.J., Blomström-Lundqvist C. et al. ESC scientific document group. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur. Heart J. 2020; 41 (5): 655–720. DOI: 10.1093/eurheartj/ehz467
- Rodseth R.N., Biccard B.M., Le Manach Y., Sessler D.I., Lurati Buse G.A., Thabane L. et al. The prognostic value of pre-operative and post- operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro- B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J. Am. Coll. Cardiol. 2014; 63 (2): 170–180. DOI: 10.1016/j.jacc.2013.08.1630
- Lopes L.M., Damiano A.P., Moreira G.N., Azevedo T.J., Nagamatsu C.T., Tavares G.M. et al. The role of echocardiography as an isolated method for indicating surgery in patients with congenital heart disease. Arq. Bras. Cardiol. 2005; 84 (5): 381–386. DOI: 10.1590/s0066- 782x2005000500006
- Iturralde P., Nava S., Sálica G., Medeiros A., Márquez M.F., Colin L. et al. Electrocardiographic characteristics of patients with Ebstein’s anomaly before and after ablation of an accessory atrioventricular pathway. J. Cardiovasc. Electrophysiol. 2006; 17 (12): 1332–1336. DOI: 10.1111/j.1540-8167.2006.00617.x
- Danielson G.K., Fuster V. Surgical repair of Ebstein’s anomaly. Ann. Surg. 1982; 196 (4): 499–504. DOI: 10.1097/00000658-198210000- 00014
- Бокерия Л.А. Тахиаритмии. Диагностика и хирургическое лечение. Л.: Медицина; 1989: 73–121.
- DeWitt E.S., Beausejour-Ladouceur V., Whitehill R., Radiofrequency ablation versus medical therapy for first episode of atrial tachycardia in adults with congenital heart disease. Heart Rhythm. 2016; 13: S449.
- Park J.B., Lee S.P., Lee J.H., Yoon Y.E., Park E.A., Kim H.K. et al. Quantification of right ventricular volume and function using single-beat three-dimensional echocardiography: A validation study with cardiac magnetic resonance. J. Am. Soc. Echocardiogr. 2016; 29 (5): 392–401. DOI: 10.1016/j.echo.2016.01.010
- Kumor M., Lipczyńska M., Biernacka E.K., Klisiewicz A., Wójcik A., Konka M. et al. Cardiac arrest and ventricular arrhythmia in adults with Ebstein anomaly and left ventricular non-compaction. J. Cardiol. 2018; 71 (5): 484–487. DOI: 10.1016/j.jjcc.2017.11.012
- Chauvaud S.M., Brancaccio G., Carpentier A.F. Cardiac arrhythmia in patients undergoing surgical repair of Ebstein’s anomaly. Ann. Thorac. Surg. 2001; 71 (5): 1547–1552. DOI: 10.1016/s0003-4975(01)02464-x
- Kirklin J.W., Barratt-Boyes B.G. Cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. 4rd ed. N.Y.; 2013.
- Negoi R.I., Ispas A.T., Ghiorghiu I., Filipoiu F., Negoi I., Hostiuc M.E. et al. Complex Ebstein’s malformation: defining preoperative cardiac anatomy and function. J. Cardiac. Surg. 2013; 28 (1): 70–81. DOI:10.1111/jocs.12032
- Jentzer J.C., DeWald T.A., Hernandez A.F. Combination of loop diuretics with thiazide-type diuretics in heart failure. J. Am. Coll. Cardiol. 2010; 56 (19): 1527–1534. DOI: 10.1016/j.jacc.2010.06.034
- Rydman R., Shiina Y., Diller G.P., Niwa K., Li W., Uemura H. et al. Major adverse events and atrial tachycardia in Ebstein’s anomaly predicted by cardiovascular magnetic resonance. Heart. 2018; 104 (1): 37–44. DOI: 10.1136/heartjnl-2017-311274
- Ahmed S., Nanda N.C., Nekkanti R., Pacifico A.D. Transesophageal three-dimensional echocardiographic demonstration of Ebstein’s anomaly. Echocardiography. 2003; 20 (3): 305–307. DOI: 10.1046/j.1540-8175.2003.03034.x
- Van Noord P.T., Scohy T.V., McGhie J., Bogers A.J. Three-dimensional transesophageal echocardiography in Ebstein’s anomaly. Interact. Cardiovasc. Thorac. Surg. 2010; 10 (5): 836–837. DOI: 10.1510/icvts.2009.229476
- Филатов А.Г., Горячев В.А. Роль электрофизиологического исследования в выборе тактики лечения патологии аномалии Эбштейна в сочетании с дополнительным предсердно-желудочковым соединением. Анналы аритмологии. 2018; 15 (4): 220–224. DOI: 10.15275/ annaritmol.2018.4.4
- Iturralde P., Nava S., Sálica G., Medeiros A., Márquez M.F., Colin L. et al. Electrocardiographic characteristics of patients with Ebstein’s anomaly before and after ablation of an accessory atrioventricular pathway. J. Cardiovasc. Electrophysiol. 2006; 17 (12): 1332–1336. DOI: 10.1111/j.1540-8167.2006.00617.x
- Zhu D., Chung H.F., Dobson A.J., Pandeya N., Giles G.G., Bruinsma F. et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet. Public. Health. 2019; 4 (11): e553–e564. DOI: 10.1016/S2468-2667(19)30155- 0
- Diller G.P., Dimopoulos K., Okonko D., Li W., Babu-Narayan S.V., Broberg C.S. et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005; 112 (6): 828–835. DOI: 10.1161/ CIRCULATIONAHA.104.529800
- Siân Pincott E., Burch M. Indications for heart transplantation in congenital heart disease. Curr. Cardiol. Rev. 2011; 7 (2): 51–58. DOI: 10.2174/157340311797484240
- Book W.M., Shaddy R.E. Medical therapy in adults with congenital heart disease. Heart Fail. Clin. 2014; 10 (1): 167–178. DOI: 10.1016/j.hfc.2013.09.006
- Диагностика и лечение ХСН у детей и подростков. Методические рекомендации. Ассоциация детских кардиологов. М.; 2010.
- Kantor P.F., Lougheed J., Dancea A., McGillion M., Barbosa N., Chan C. et al. Children’s Heart Failure Study Group. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can. J. Cardiol. 2013; 29 (12): 1535–1552. DOI: 10.1016/j.cjca.2013.08.008
- Priori S.G., Blomström-Lundqvist C. 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur. Heart J. 2015; 36 (41): 2757–2759. DOI: 10.1093/eurheartj/ehv445
- Budts W., Börjesson M., Chessa M., van Buuren F., Trigo Trindade P., Corrado D. et al. Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription. Eur. Heart J. 2013; 34 (47): 3669–3674. DOI: 10.1093/eurheartj/eht433
- Gheorghiade M., Patel K., Filippatos G., Anker S.D., van Veldhuisen D.J., Cleland J.G. et al. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur. J. Heart Fail. 2013; 15 (5): 551–559. DOI: 10.1093/eurjhf/hft010
- Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003; 289 (7): 871–878. DOI: 10.1001/jama.289.7.871
- Bosnic Z. et al. Pathophysiological complexity of amiodarone-induced hypothyroidism (AIH) in patient with congenital heart disease – Ebstein anomaly: a case report. 2021. DOI: 10.21203/rs.3.rs-304220/v1
- Hernández-Madrid A., Paul T., Abrams D., Aziz P.F., Blom N.A., Chen J. et al. ESC Scientific Document Group. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018; 20 (11): 1719–1753. DOI: 10.1093/europace/eux380
- Beaufort-Krol G.C., Dijkstra S.S., Bink-Boelkens M.T. Natural history of ventricular premature contractions in children with a structurally normal heart: does origin matter? Europace. 2008; 10 (8): 998–1003. DOI: 10.1093/europace/eun121
- Wang S., Zhu W., Hamilton R.M., Kirsh J.A., Stephenson E.A., Gross G.J. Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts. Heart Rhythm. 2010; 7 (12): 1725–1731. DOI: 10.1016/j.hrthm.2010.07.037
- Collins K.K., Schaffer M.S., Liberman L., Saarel E., Knecht M., Tanel R.E. et al. Pediatric and Congenital Electrophysiology Society. Fascicular and nonfascicular left ventricular tachycardias in the young: an international multicenter study. J. Cardiovasc. Electrophysiol. 2013; 24 (6): 640–648. DOI: 10.1111/jce.12105
- Pappone C., Vicedomini G., Manguso F., Baldi M., Pappone A., Petretta A. et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation. 2012; 125 (5): 661–668. DOI: 10.1161/CIRCULATIONAHA.111.065722
- Renda G., Ricci F., Giugliano R.P., De Caterina R. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease. J. Am. Coll. Cardiol. 2017; 69 (11): 1363–1371. DOI: 10.1016/j.jacc.2016.12.038
- Roldán V., Marín F., Manzano-Fernández S., Gallego P., Vílchez J.A., Valdés M. et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J. Am. Coll. Cardiol. 2013; 62(23): 2199–2204. DOI: 10.1016/j.jacc.2013.08.1623
- Khairy P., Van Hare G.F., Balaji S., Berul C.I., Cecchin F., Cohen M.I. et al. PACES/HRS Expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014; 11 (10): e102–165. DOI: 10.1016/j.hrthm.2014.05.009
- Ahmed H., VanderPluym C. Medical management of pediatric heart failure. Cardiovasc. Diagn. Ther. 2021; 11 (1): 323–335. DOI: 10.21037/cdt-20-358
- Heidbuchel H., Verhamme P., Alings M., Antz M., Diener H.C., Hacke W. et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015; 17 (10): 1467–1507. DOI: 10.1093/europace/euv309
- Giglia T.M., Massicotte M.P., Tweddell J.S., Barst R.J., Bauman M., Erickson C.C. et al. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013; 128 (24): 2622–2703. DOI: 10.1161/01.cir.0000436140.77832.7a
- Jensen A.S., Idorn L., Nørager B., Vejlstrup N., Sondergaard L. Anticoagulation in adults with congenital heart disease: the who, the when and the how? Heart. 2015; 101 (6): 424–429. DOI: 10.1136/heartjnl-2014-305576
- Waldmann V., Laredo M., Abadir S., Mondésert B., Khairy P. Atrial fibrillation in adults with congenital heart disease. Int. J. Cardiol. 2019; 287: 148–154. DOI: 10.1016/j.ijcard.2019.01.079
- Olesen J.B., Lip G.Y., Hansen M.L., Hansen P.R., Tolstrup J.S., Lindhardsen J. et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011; 342: d124. DOI: 10.1136/bmj.d124
- Di Russo G.B., Gaynor J.W. Ebstein’s anomaly: indications for repair and surgical technique. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 1999; 2: 35–50. DOI: 10.1016/s1092-9126(99)70004-9
- Prakash S., Agarwal S., Singh A.K. et al. Bioprosthetic valve replacement in Ebstein’s anomaly. Indian J. Thorac. Cardiovasc. Surg. 2010; 26: 179–184. DOI: 10.1007/s12055-010-0031-y
- Pujol C., Niesert A.C., Engelhardt A., Schoen P., Kusmenkov E., Pittrow D. et al. Usefulness of direct oral anticoagulants in adult congenital heart disease. Am. J. Cardiol. 2016; 117 (3): 450–455. DOI: 10.1016/j.amjcard.2015.10.062
- Belli E., Rabot M., Petit J., Gouton M. Ebstein’s anomaly in adults: modified cone reconstruction of the tricuspid valve is associated with promising outcomes. Arch. Cardiovasc. Dis. 2017; 110 (5): 325–333. DOI: 10.1016/j.acvd.2017.03.003
- Bradley S.M., Sade R.M., Crawford F.A. Jr, Stroud M.R. Anticoagulation in children with mechanical valve prostheses. Ann. Thorac. Surg. 1997; 64 (1): 30–34; discussion 35–36. DOI: 10.1016/s0003-4975(97)00453-0
- Holst K.A., Connolly H.M., Dearani J.A. Ebstein’s anomaly. Methodist Debakey Cardiovasc. J. 2019; 15 (2): 138–144. DOI: 10.14797/mdcj- 15-2-138
- Van Slooten Y.J., Freling H.G., van Melle J.P., Mulder B.J., Jongbloed M.R., Ebels T. et al. Long-term tricuspid valve prosthesis-related complications in patients with congenital heart disease. Eur. J. Cardiothorac. Surg. 2014; 45 (1): 83–89. DOI: 10.1093/ejcts/ezt259
- Boston U.S., Dearani J.A., O’Leary P.W., Driscoll D.J., Danielson G.K. Tricuspid valve repair for Ebstein’s anomaly in young children: a 30-year experience. Ann. Thorac. Surg. 2006; 81 (2): 690–695; discussion 695–696. DOI: 10.1016/j.athoracsur.2005.08.011
- Ross F.J., Latham G.J., Richards M., Geiduschek J., Thompson D., Joffe D. Perioperative and anesthetic considerations in Ebstein’s anomaly. Semin. Cardiothorac. Vasc. Anesth. 2015; 20 (1): 82–92. DOI: 10.1177/1089253215605390
- Sherwin E.D., Abrams D.J. Ebstein anomaly. Card. Electrophysiol. Clin. 2017; 9 (2): 245–254. DOI: 10.1016/j.ccep.2017.02.007
- Da Silva J.P., Baumgratz J.F., da Fonseca L., Franchi S.M., Lopes L..M, Tavares G.M. et al. The cone reconstruction of the tricuspid valve in Ebstein’s anomaly. The operation: early and midterm results. J. Thorac. Cardiovasc. Surg. 2007; 133 (1): 215–223. DOI: 10.1016/j. jtcvs.2006.09.018
- Orczykowski M., Derejko P., Bodalski R., Urbanek P., Zakrzewska-Koperska J., Sierpiński R. et al. Radiofrequency catheter ablation of accessory pathways in patients with Ebstein’s anomaly: at 8 years of follow-up. Cardiol. J. 2017; 24 (1): 1–8. DOI: 10.5603/CJ.a2016.0111
- Horstkotte D., Friedrichs W., Pippert H., Bircks W., Loogen F. Benefits of endocarditis prevention in patients with prosthetic heart valves. Z. Kardiol. 1986; 75 (1): 8–11.
- Holst K.A., Connolly H.M., Dearani J.A. Ebstein’s anomaly. Methodist Debakey Cardiovasc. J. 2019; 15 (2): 138–144. DOI: 10.14797/mdcj- 15-2-138
- Siripornpitak S., Goo H.W. CT and MRI for repaired complex adult congenital heart diseases. Korean J. Radiol. 2021; 22 (3): 308–323. DOI: 10.3348/kjr.2020.0895
- Qureshi M.Y., Dearani J.A. Commentary: gold or silver? Value of cardiac magnetic resonance imaging over echocardiography in Ebstein’s anomaly. J. Thorac. Cardiovasc. Surg. 2021; 161 (3): 1109–1110. DOI: 10.1016/j.jtcvs.2020.11.016
- Qureshi M.Y., O’Leary P.W., Connolly H.M. Cardiac imaging in Ebstein anomaly. Trends Cardiovasc. Med. 2018; 28 (6): 403–409. DOI: 10.1016/j.tcm.2018.01.002
- Yang D., Li X., Sun J.Y., Cheng W., Greiser A., Zhang T.J. et al. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein’s anomaly. J. Cardiovasc. Magn. Reson. 2018; 20 (1): 69. DOI: 10.1186/ s12968-018-0488-1
- Steinmetz M., Broder M., Hösch O., Lamata P., Kutty S., Kowallick J.T. et al. Atrio-ventricular deformation and heart failure in Ebstein’s anomaly – a cardiovascular magnetic resonance study. Int. J. Cardiol. 2018; 257: 54–61. DOI: 10.1016/j.ijcard.2017.11.097
- Baessato F., Furtmüller C., Shehu N., Ferrari I., Reich B., Nagdyman N. et al. Detection of early signs of right ventricular systolic impairment in unoperated Ebstein’s anomaly by cardiac magnetic resonance feature tracking. Cardiovasc. Diagn. Ther. 2022; 12 (3): 278–288. DOI: 10.21037/cdt-22-82
- Trivedi J.K., Mahapatra R.P., Gandham R.K., Ramakrishna G.V., Satapathy S.K., Mohanty S.K., Suresh A. Ebstein’s anomaly presenting with the acute coronary syndrome – a rare combination. Indian J. Thorac. Cardiovasc. Surg. 2020; 36 (1): 56–59. DOI: 10.1007/s12055-019- 00840-z
- Attenhofer Jost C.H., Connolly H.M., O’Leary P.W., Warnes C.A., Tajik A.J., Seward J.B. Left heart lesions in patients with Ebstein anomaly. Mayo Clin. Proc. 2005; 80 (3): 361–368. DOI: 10.4065/80.3.361
- Warnes C.A., Williams R.G., Bashore T.M., Child J.S., Connolly H.M., Dearani J.A. et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology / American Heart Association task force on practice guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 2008; 52 (23): e143–e263. DOI: 10.1016/j.jacc.2008.10.001
- Saxena A., Relan J., Agarwal R., Awasthy N., Azad S., Chakrabarty M. et al. Indian guidelines for indications and timing of intervention for common congenital heart diseases: revised and updated consensus statement of the Working group on management of congenital heart diseases. Ann. Pediatr. Cardiol. 2019; 12 (3): 254–286. DOI: 10.4103/apc.APC_32_19
- Schultz K., Haeffele C.L. Heart failure in the adult Ebstein patient. Heart Fail. Rev. 2020; 25 (4): 623–632. DOI: 10.1007/s10741-020-09930- 2
- Holst K.A., Dearani J.A. Diagnosis and management of adult congenital heart disease. III ed. 2011: 46.
- Dinardo J.A. Heart failure associated with adult congenital heart disease. Semin. Cardiothorac. Vasc. Anesth. 2013; 17 (1): 44–54. DOI: 10.1177/1089253212469841
- Shaddy R.E., Webb G. Applying heart failure guidelines to adult congenital heart disease patients. Expert Rev. Cardiovasc. Ther. 2008; 6 (2): 165–174. DOI: 10.1586/14779072.6.2.165
- Fuchs M.M., Connolly H.M. Ebstein anomaly in the adult patient. Cardiol. Clin. 2020; 38 (3): 353–363. DOI: 10.1016/j.ccl.2020.04.004
- Tam B., Chhay A., Yen L., Tesoriero L., Ramanathan R., Seri I., Friedlich P.S. Acetazolamide for the management of chronic metabolic alkalosis in neonates and infants. Am. J. Ther. 2014; 21 (6): 477–481. DOI: 10.1097/MJT.0b013e31825e792c
- Andrews M.G., Johnson P.N., Lammers E.M., Harrison D.L., Miller J.L. Acetazolamide in critically ill neonates and children with metabolic alkalosis. Ann. Pharmacother. 2013; 47 (9): 1130–1135. DOI: 10.1177/1060028013500468
- Haas N.A., Schirmer K.R. Guidelines for the management of congenital heart diseases in childhood and adolescence. Cardiol. Young. 2017; 27 (S3): S1–S105. DOI: 10.1017/S1047951116001955
- Klinge J.M., Scharf J., Hofbeck M., Gerling S., Bonakdar S., Singer H. Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery. Intensive Care Med. 1997; 23 (6): 693–697. DOI: 10.1007/ s001340050395
- Jain S., Vaidyanathan B. Digoxin in management of heart failure in children: should it be continued or relegated to the history books? Ann. Pediatr. Cardiol. 2009; 2 (2): 149–152. DOI: 10.4103/0974-2069.58317
- Echt D.S., Liebson P.R., Mitchell L.B., Peters R.W., Obias-Manno D., Barker A.H. et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N. Engl. J. Med. 1991; 324 (12): 781–788. DOI: 10.1056/ NEJM199103213241201
- Saul J.P., Scott W.A., Brown S., Marantz P., Acevedo V., Etheridge S.P. et al.; Intravenous Amiodarone Pediatric Investigators. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation. 2005; 112 (22): 3470–3477. DOI: 10.1161/CIRCULATIONAHA.105.534149
- Labombarda F., Ou P., Stos B., de Blic J., Villain E., Sidi D. Acute amiodarone-induced pulmonary toxicity: an association of risk factors in a child operated by arterial switch operation. Congenit. Heart Dis. 2008; 3 (5): 365–367. DOI: 10.1111/j.1747-0803.2008.00208.x
- Haas N.A., Camphausen C.K. Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients wit postoperative tachyarrhythmia. J. Thorac. Cardiovasc. Surg. 2008; 136 (5): 1215–1222. DOI: 10.1016/j.jtcvs.2008.04.011
- Thorne S.A., Barnes I., Cullinan P., Somerville J. Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation. 1999; 100 (2): 149–154. DOI: 10.1161/01.cir.100.2.149
- Moe T.G., Abrich V.A., Rhee E.K. Atrial fibrillation in patients with congenital heart disease. J. Atr. Fibrillation. 2017; 10 (1): 1612. DOI: 10.4022/jafib.1612
- Moore B.M., Cordina R.L., McGuire M.A., Celermajer D.S. Efficacy and adverse effects of sotalol in adults with congenital heart disease. Int. J. Cardiol. 2019; 274: 74–79. DOI: 10.1016/j.ijcard.2018.06.066
- Malloy-Walton L.E., Von Bergen N.H., Balaji S., Fischbach P.S., Garnreiter J.M., Asaki S.Y. et al. IV Sotalol use in pediatric and congenital heart patients: a multicenter registry study. J. Am. Heart Assoc. 2022; 11 (9): e024375. DOI: 10.1161/JAHA.121.024375
- Colli A., Verhoye J.P., Heijmen R., Strauch J.T., Hyde J.A., Pagano D. et al. ACTION Registry Investigators. Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results. Eur. J. Cardiothorac. Surg. 2008; 33 (4): 531–536. DOI: 10.1016/ j.ejcts.2007.12.019
- ElBardissi A.W., DiBardino D.J., Chen F.Y., Yamashita M.H., Cohn L.H. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm? J. Thorac. Cardiovasc. Surg. 2010; 139 (5): 1137–1145. DOI: 10.1016/j.jtcvs.2009.10.064
- Nowell J., Wilton E., Markus H., Jahangiri M. Antithrombotic therapy following bioprosthetic aortic valve replacement. Eur. J. Cardiothorac. Surg. 2007; 31 (4): 578–585. DOI: 10.1016/j.ejcts.2006.12.017
- Bonow R.O., Carabello B.A., Kanu C., de Leon A.C. Jr., Faxon D.P., Freed M.D. et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006; 114 (5): e84–231. DOI: 10.1161/CIRCULATIONAHA.106.176857
- Купряшов А.А., Токмакова К.А. Нарушения системы свёртывания крови в сердечно-сосудистой хирургии. В кн.: Система гемостаза. Теоретические основы и клиническая практика: Национальное руководство. М.: ГЭОТАР-Медиа; 2024.
- Boucher A.A., Heneghan J.A., Jang S., Spillane K.A., Abarbanell A.M., Steiner M.E., Meyer A.D. A narrative review of postoperative anticoagulation therapy for congenital cardiac disease. Front Surg. 2022; 9: 907782. DOI: 10.3389/fsurg.2022.907782
- Monagle P., Chan A.K.C., Goldenberg N.A., Ichord R.N., Journeycake J.M., Nowak-Göttl U., Vesely S.K. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis. 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl): e737S–e801S. DOI: 10.1378/chest.11-2308
- Separham A., Ghaffari S., Aslanabadi N., Sohrabi B., Ghojazadeh M., Anamzadeh E. et al. Prosthetic valve thrombosis. J. Card. Surg. 2015; 30 (3): 246–250. DOI: 10.1111/jocs.12510
- Van Nooten G.J., Caes F., Taeymans Y., Van Belleghem Y., François K., De Bacquer D. et al. Tricuspid valve replacement: postoperative and long-term results. J. Thorac. Cardiovasc. Surg. 1995; 110 (3): 672–679. DOI: 10.1016/S0022-5223(95)70098-6
- Thorburn C.W., Morgan J.J., Shanahan M.X., Chang V.P. Long-term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis. Am. J. Cardiol. 1983; 51 (7): 1128–1132. DOI: 10.1016/0002-9149(83)90357-0
- Yaminisharif A., Alemzadeh-Ansari M.J., Ahmadi S.H. Prosthetic tricuspid valve thrombosis: three case reports and literature review. J. Tehran. Heart Cent. 2012; 7 (4): 147–155.
- Shin H.S., Kim K.H., Lee H.S., Choi H.M., Lee S.A., Park E.A., Kim H.K. Organized prosthetic tricuspid valve thrombosis treated successfully with medical treatment. J. Cardiovasc. Ultrasound. 2013; 21 (4): 192–196. DOI: 10.4250/jcu.2013.21.4.192
- Подзолков В.П., Кассирский Г.И. (ред.). Реабилитация больных после хирургического лечения врожденных пороков сердца. М.: НЦССХ им. А.Н. Бакулева РАМН; 2015.
- Подзолков В.П., Алекян Б.Г., Кокшенев И.В., Чебан В.Н. Повторные операции после коррекции врожденных пороков сердца. М.: НЦССХ им. А.Н. Бакулева РАМН; 2013.
- Демин А.А., Кобалава Ж.Д., Скопин И.И. и др. Инфекционный эндокардит и инфекция внутрисердечных устройств. Клинические рекомендации 2021. Российский кардиологический журнал. 2022; 27 (10): 5233. DOI:10.15829/1560-4071-2022-5233
